RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling
Yao, Z; Gao, YJ; Su, WJ; Yaeger, R; Tao, J; Na, N; Zhang, Y; Zhang, C; Rymar, A; Tao, A; Timaul, NM; Mcgriskin, R; Outmezguine, NA; Zhao, H; Chang, Q; Qeriqi, B; Barbacid, M; de Stanchina, E; Hyman, DM; Bollag, G; Rosen, N
Rosen, N (reprint author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, 1275 York Ave, New York, NY 10021 USA.; Rosen, N (reprint author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Rosen, N (reprint author), M
NATURE MEDICINE, 2019; 25 (2): 284